Falk Re
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Organ Transplantation Techniques and Outcomes
- Pancreatic function and diabetes
- Colorectal and Anal Carcinomas
Papers in
- Co-authors
- L Makowka (14 shared papers)B Langer (3 shared papers)Phillips Mj (3 shared papers)Blendis Lm (3 shared papers)U Ambus (9 shared papers)Bruce Taylor (1 shared paper)Stefano Landi (5 shared papers)B Langer (2 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)HemaSphere (1 paper)PubMed (35 papers)
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
Falk Re
34 papers receiving 325 citations
Peers
Comparison fields: 5 of 56
- Hepatology 187
- Surgery 196
- Oncology 59
- Immunology 44
- Pharmacology 16
Countries citing papers authored by Falk Re
This map shows the geographic impact of Falk Re's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Falk Re with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Falk Re more than expected).
Fields of papers citing papers by Falk Re
This network shows the impact of papers produced by Falk Re. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Falk Re. The network helps show where Falk Re may publish in the future.
Co-authors
The 25 scholars most cited alongside Falk Re, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reversal of toxic and anoxic induced hepatic failure by syngeneic, allogeneic, and xenogeneic hepatocyte transplantation. | 1980 | 90 |
| 2 | Studies into the mechanism of reversal of experimental acute hepatic failure by hepatocyte transplantation. 1. | 1981 | 41 |
| 3 | Role of resection in the management of metastases to the liver. | 1983 | 26 |
| 4 | Reversal of lethal, chemotherapeutically induced acute hepatic necrosis in rats by regenerating liver cytosol. | 1983 | 21 |
| 5 | Immunostimulation with intraperitoneally administered bacille Calmette Guérin for advanced malignant tumors of the gastrointestinal tract. | 1976 | 19 |
| 6 | Pelvic exenteration for advanced primary and recurrent adenocarcinoma. | 1985 | 17 |
| 7 | In vitro correlates of transplantation immunity: the release of substances by immune lymphocytes confronted with specific antigens. | 1969 | 15 |
| 8 | Partial trisomy of chromosome 11: a case report. | 1973 | 12 |
| 9 | Allogeneic and xenogeneic hepatocyte transplantation. | 1981 | 10 |
| 10 | Intermittent percutaneous infusion into the hepatic artery of cytotoxic drugs for hepatic tumours. | 1982 | 9 |
| 11 | Allogeneic intrasplenic hepatocyte transplantation in the Gunn rat using cyclosporine A immunosuppression. | 1987 | 8 |
| 12 | Excision of abdominal wall tumours and reconstruction with Marlex mesh. | 1986 | 8 |
| 13 | Chromosome studies on cultured tumors of nervous tissue origin. | 1967 | 8 |
| 14 | The effect of radiofrequency hyperthermia and chemotherapy upon human neoplasms when used with adjuvant metronidazole. | 1983 | 7 |
| 15 | Oral bacille Calmette Guérin immunostimulation in malignant melanoma. | 1975 | 6 |
| 16 | Effective antitumor immunity following elimination of suppressor T cell function. | 1978 | 6 |
| 17 | Serologic cross-reaction of murine and human Ia antigens. | 1979 | 5 |
| 18 | A family with concurrent mesomelic shortening and hereditary nephritis. | 1976 | 5 |
| 19 | Comparison of the antitumor effects of a synthetic biopolymer and standard adjuvants. | 1980 | 5 |
| 20 | Prenatal diagnosis of a 5/15 translocation with 5p and proximal 5q trisomy. Cytogenetic and phenotypic findings. | 1982 | 4 |
About Falk Re
Falk Re is a scholar working on Oncology, Surgery, Immunology, Genetics and Hepatology, having authored 37 papers that have together received 350 indexed citations. Recurring topics across this work include Liver physiology and pathology (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (5 papers), Cancer Research and Treatments (5 papers), Immune Cell Function and Interaction (4 papers), Organ Transplantation Techniques and Outcomes (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Hepatology (187 citations), Surgery (196 citations), Oncology (59 citations), Immunology (44 citations) and Pharmacology (16 citations). Falk Re has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include L Makowka, B Langer, Phillips Mj, Blendis Lm, U Ambus, Bruce Taylor, Stefano Landi, B Langer, Göran Möller and L Collste. Their work appears in journals such as Journal of Clinical Oncology, HemaSphere and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.